Multiple Sclerosis and COVID-19: An Overview on Risk, Severity, and Association With Disease Modifying Therapies
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel coronavirus, emerged in December 2019, sparking a global health crisis. While initially recognized as a respiratory illness, it has become evident that Coronavirus disease 2019 (COVID-19) also affects the central nervous system. T...
Saved in:
Main Authors: | Mary Hollist, Abraham Hollist, Katherine Au, Colton Betts, Maha Kirmani, Maaida Kirmani, Benjamin Armour, Mercy C Udeh, Batool F Kirmani |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2024-09-01
|
Series: | Neuroscience Insights |
Online Access: | https://doi.org/10.1177/26331055241265668 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
Similar Items
-
Importance of Video-EEG Monitoring in the Diagnosis of Refractory Panic Attacks
by: Batool F. Kirmani, et al.
Published: (2013-01-01) -
Presentation of Bilateral Peripheral Seventh Cranial Nerve Palsy in an HIV Patient
by: Lisa M. Ruiz, et al.
Published: (2012-01-01) -
Novel Homozygous TTI2 Variant Causing Autosomal Recessive Syndromic Intellectual Disability and Primary Microcephaly from Pakistan: A Case Report (Exome Report)
by: Zul Qarnain, et al.
Published: (2022-01-01) -
Multiple sclerosis: overview of orally administrated disease-modifying drugs. Do genetics influence the success of treatment?
by: A. Ovčinikova, et al.
Published: (2019-03-01) -
Repetitive Transcranial Magnetic Stimulation, Cognition, and Multiple Sclerosis: An Overview
by: Grigorios Nasios, et al.
Published: (2018-01-01)